- Home
- RGS vs HRTX Comparison
RGS vs HRTX Comparison
Compare RGS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGS | HRTX |
|---|---|---|
| Founded | 1922 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.6M | 61.2M |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RGS | HRTX |
|---|---|---|
| Price | $29.45 | $0.30 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 2.2M |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | ★ $224,485,000.00 | $154,904,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.68 | N/A |
| P/E Ratio | $12.22 | ★ N/A |
| Revenue Growth | 6.83 | ★ 7.36 |
| 52 Week Low | $19.31 | $0.26 |
| 52 Week High | $30.93 | $1.58 |
Technical Indicators
Market Signals| Indicator | RGS | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 41.31 |
| Support Level | $26.23 | $0.29 |
| Resistance Level | $29.65 | $0.34 |
| Average True Range (ATR) | 0.60 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 76.93 | 13.60 |
Price Performance
Historical ComparisonAbout RGS Regis Corporation
Regis Corporation franchises, owns, and operates hair care salons, mainly in North America, with licensed locations in the U.K. Its salons provide haircutting, styling, shampooing and conditioning, hair coloring and related services, and also sell hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, Cost Cutters, First Choice Haircutters and Roosters. Its operating segments are Franchise and Company-Owned, with the majority of its revenue generated from the Franchise segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.